HomeDNLI • NASDAQ
add
Denali Therapeutics Inc
Previous close
$12.50
Day range
$12.02 - $12.73
Year range
$10.57 - $33.32
Market cap
1.84B USD
Avg Volume
1.64M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 30.06M | 21.36% |
Net income | -114.75M | 3.95% |
Net profit margin | — | — |
Earnings per share | -0.67 | 22.09% |
EBITDA | -129.57M | 6.31% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 832.33M | -19.54% |
Total assets | 1.37B | 19.09% |
Total liabilities | 144.50M | 17.51% |
Total equity | 1.23B | — |
Shares outstanding | 145.22M | — |
Price to book | 1.47 | — |
Return on assets | -22.96% | — |
Return on capital | -24.45% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -114.75M | 3.95% |
Cash from operations | -83.72M | 15.15% |
Cash from investing | 172.21M | 135.75% |
Cash from financing | -4.17M | -188.59% |
Net change in cash | 84.32M | 503.37% |
Free cash flow | -55.23M | -7.65% |
About
Founded
2013
Headquarters
Website
Employees
422
